Bugs n drugs - Emory University
Treatment of polymicrobial infection iii. Empiric therapy in immunocompromised patient iv. Synergism with certain combinations ... Rheumatic fever, prophylaxis, syphilis Procaine Penicillin (IM) Pharyngitis ... tissue infections and peritonitis Imipenem (IV – Primaxin)
Download Bugs n drugs - Emory University
Information
Domain:
Source:
Link to this page:
Documents from same domain
Sedation, Analgesia, and Paralysis in the Intensive Care ...
edmedia.emory.eduSociety of Critical Care Medicine and American Society of Health-System Pharmacists. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Am J Health-Syst Pharm. 2001;59:179-95. 11. Hunter JM. New neuromuscular blocking drugs.
I MANAGEMENT OF POISONING AND DRUG OVERDOSE - …
edmedia.emory.eduI MANAGEMENT OF POISONING AND DRUG OVERDOSE Kent R. Olson, m.d. Manish M. Patel, m.d. Drug overdose and poisoning are leading causes of emergency department visits and hospital admissions in the United States, accounting for more than 250,000 emergency department visits 1 and 7,000 deaths 2 each year. Exposure to poison can occur in sev-eral …
Related documents
DRUG NAME: Cytarabine
www.bccancer.bc.catherapy, frequency of treatment, and the use of combination therapy. 4,10. Pregnancy: FDA Pregnancy Category D. 4. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for
Guidelines UK guidelines on the management of variceal ...
www.bsg.org.ukbacterial peritonitis, renal impair-ment and hypotension (level 2b, grade B). ... Percentage of patients receiving primary prophylaxis among those newly diagnosed with grade I varices and red signs or grade 2–3 varices. ... endoscopic treatment, TIPSS or surgery is performed depending on local resources and expertise (level 1b, grade B).
Aminoglycoside Dosing in Adults - Queensland Health
www.health.qld.gov.ausurgical prophylaxis (refer to local guidelines if available or eTG Topic | Therapeutic Guidelines ), peritonitis in peritoneal dialysis patients (refer to statewide clinical pathway Peritonitis in PD patients) use of amikacin in mycobacterial infections (refer to the Tuberculosis Expert Advisory Group (TEAG) guideline TEAG guidelines).